July 8, 2021 | https://vimeo.com/564557480, www.cervicalcancer-risk.com
An all-female team at Mind+Matter has created a campaign for Roche that takes a tongue-in-cheek approach to tackle taboos about going for a smear test.
The month-long ‘The Smear Word’ campaign, which launched this week, is centred on a three-minute film that depicts a young woman going for her first smear test.
It provides simple facts about what is involved in the cervical screening, in a scenario in which a young woman repeatedly makes asides to the camera about aspects of the smear test she is worried about. These are addressed by the nurse in the film, who explains to the viewer what is involved.
Cervical screening prevents at least 2,000 deaths in the UK each year, according to Cancer Research UK.
Women aged between 25 and 29 are the target audience of the new campaign, which aims to encourage them to attend screening appointments. Many young women do not turn up for appointments, which puts them at risk of early signs of cervical cancer being missed.
Currently, one in four young women fails to show up for screening appointments. The campaign is urging women to call their GP to book an appointment without delay, with another key message being that spending a few minutes having a smear test could save your life – with cervical cancer highly preventable through regular screening and vaccination.
The campaign is combining social and earned media along with paid activity, such as adverts on Spotify, Facebook, and Instagram to drive people to visit a campaign website that features the film.
Paid activity is being targeted in areas of the UK where a high proportion of young women are not going for screening, such as the North East, North West, Yorkshire & Humber, West Midlands and East of England.
Claudette Malone, Roche client lead at Mind+Matter, said: “Cervical screening is one of those topics that is never discussed, and yet would greatly benefit so many people around the world if we addressed anxieties, uncovered what actually takes place at appointments and raise the importance of this screening.”
She added: “From the moment we kicked off this campaign with the team at Roche Diagnostics, we knew this was an opportunity to do something different, start much-needed conversations, empower women and people with a cervix to own their health and have the confidence to go for their smear tests.”
This content was provided by Inizio
Latest Content from Inizio
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.
The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
